Reporting Owner Activity for Scott Michael Habig

Form 3/4/5 issuer positions and transaction evidence for this reporting owner.

Issuer positions

1

Largest position

Aurinia Pharmaceuticals Inc.

Disclosed value

$2.42M

Recent activity

Available

SEC ownership signals 1 signal
Forms 3/4/5 ownership summary

Estimated reporting-owner value

$2,423,155

Estimated from parsed Forms 3/4/5 when filings disclose enough holding data.

Issuers in parsed filings

1

Distinct issuers connected to this reporting owner in parsed SEC filings.

Largest reported issuer position

Aurinia Pharmaceuticals Inc. (AUPH)

$2.42M estimated from parsed reporting-owner filings.

Latest owner filing

08 Aug 2024

Most recent owner-level filing date in the parsed SEC record.

How to read Forms 3/4/5 positions
  • Reported values are estimates from parsed SEC Forms 3/4/5 when the filing includes enough price and share data.
  • Verify the source filing before treating any owner position as current.
Identity 1 identity field
Location
Victoria, British Columbia, Canada
SEC filing record 1 source field
Reporting-owner signature
/s/ Scott Habig
SEC evidence 1 source field
SEC filing history
Open SEC filing history

Follow Filing Activity

Follow Scott Michael Habig and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Reported issuer positions for Scott Michael Habig

Recent insider transactions for Scott Michael Habig

Sym Company Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .